The principal objective in a new drug development program is to assess the benefit / risk ratio. Learn what the risk information is that must be collected, documented and reported accurately.
The Risk to Subject Safety of Not Accurately Reporting Adverse Events - How to Assess and report AEs and SAEs - By GlobalCompliancePanel
14 June 2011, Wilmington, United States
Introduction
Venue
Online Training Webinars
Online Training Webinars, 1000 N West Street | Suite 1200, Wilmington, 19801, United States
Useful links
Contact information
Mr
United States of America
United States of America
Related events
What's in that Perfume? - The 91AV behind an iconic Christmas gift
3 December 2024 18:00-20:00, London, United Kingdom
Joint SoBRA / RSC Winter Conference 2024 Current Issues in Contaminated Land Risk Assessment
10 December 2024 09:45-18:00, London, United Kingdom
From bench to bedside - Advancements in prosthetic/artificial heart valve devices
25 February 2025 17:00-18:30
Royal Australian Chemical Institute 2nd Green and Sustainable 91AV and Engineering Conference
8 December 2024 17:00 - 12 December 2024 15:00, Melbourne, Australia
Search
Advertisement
Spotlight
Explore
Membership
